[ad_1]
GAITHERSBURG, Md., Feb. 21, 2022 /PRNewswire/ — Novavax, Inc. (NASDAQ:NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced it will report its fourth quarter and full year 2021 financial results and operational highlights on Monday, February 28, 2022following the close of US financial markets. Details of the event and replay are as follows:
|
Conference call details: |
||
|
Date: |
February 28, 2022 |
|
|
Time: |
4:30 pm US Eastern Standard Time (EST) |
|
|
Dial-in number: |
(877) 870-4263 (Domestic) or (412) 317-0790 (International) |
|
|
Webcast: |
||
|
• |
Participants … |
|
Full story available on Benzinga.com
[ad_2]
Source link
